BACKGROUND: Coronary artery disease (CAD) is the major cause of death in patients with type 2 diabetes mellitus. Although demographic and clinical factors associated with extent of CAD in patients with diabetes mellitus have been described, genetic factors have not. We hypothesized that genetic variation in peroxisome proliferator-activated receptor (PPAR) pathway genes, important in diabetes mellitus and atherosclerosis, would be associated with extent of CAD in patients with diabetes mellitus. METHODS AND RESULTS: We genotyped 1043 patients (702 white, 175 blacks) from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) genetic cohort for 3351 variants in 223 PPAR pathway genes using a custom targeted-genotyping array. Angiographic end points were determined by a core laboratory. In whites, a single variant (rs1503298) in TLL1 was significantly (P=5.5 × 10(-6)) associated with extent of CAD, defined as number of lesions with percent diameter stenosis ≥20%, after stringent Bonferroni correction for all 3351 single nucleotide polymorphisms. This association was validated in the diabetic subgroups of 2 independent cohorts, the Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH) post-myocardial infarction registry and the prospective Family Heart Study (FHS) of individuals at risk for CAD. TLL1rs1503298 was also significantly associated with extent of severe CAD (≥70% diameter stenosis; P=3.7 × 10(-2)) and myocardial jeopardy index (P=8.7 × 10(-4)). In general linear regression modeling, TLL1rs1503298 explained more variance of extent of CAD than the previously determined clinical factors. CONCLUSIONS: We identified a variant in a single PPAR pathway gene, TLL1, that is associated with the extent of CAD independently of clinical predictors, specifically in patients with type 2 diabetes mellitus and CAD. Clinical Trial Registration- URL: http://www.clinicaltrials.gov. Unique identifier: NCT00006305.
RCT Entities:
BACKGROUND:Coronary artery disease (CAD) is the major cause of death in patients with type 2 diabetes mellitus. Although demographic and clinical factors associated with extent of CAD in patients with diabetes mellitus have been described, genetic factors have not. We hypothesized that genetic variation in peroxisome proliferator-activated receptor (PPAR) pathway genes, important in diabetes mellitus and atherosclerosis, would be associated with extent of CAD in patients with diabetes mellitus. METHODS AND RESULTS: We genotyped 1043 patients (702 white, 175 blacks) from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) genetic cohort for 3351 variants in 223 PPAR pathway genes using a custom targeted-genotyping array. Angiographic end points were determined by a core laboratory. In whites, a single variant (rs1503298) in TLL1 was significantly (P=5.5 × 10(-6)) associated with extent of CAD, defined as number of lesions with percent diameter stenosis ≥20%, after stringent Bonferroni correction for all 3351 single nucleotide polymorphisms. This association was validated in the diabetic subgroups of 2 independent cohorts, the Translational Research Investigating Underlying Disparities in Acute Myocardial InfarctionPatients' Health Status (TRIUMPH) post-myocardial infarction registry and the prospective Family Heart Study (FHS) of individuals at risk for CAD. TLL1rs1503298 was also significantly associated with extent of severe CAD (≥70% diameter stenosis; P=3.7 × 10(-2)) and myocardial jeopardy index (P=8.7 × 10(-4)). In general linear regression modeling, TLL1rs1503298 explained more variance of extent of CAD than the previously determined clinical factors. CONCLUSIONS: We identified a variant in a single PPAR pathway gene, TLL1, that is associated with the extent of CAD independently of clinical predictors, specifically in patients with type 2 diabetes mellitus and CAD. Clinical Trial Registration- URL: http://www.clinicaltrials.gov. Unique identifier: NCT00006305.
Authors: Christopher S Carlson; Michael A Eberle; Mark J Rieder; Qian Yi; Leonid Kruglyak; Deborah A Nickerson Journal: Am J Hum Genet Date: 2003-12-15 Impact factor: 11.025
Authors: Anna Csiszar; Mansoor Ahmad; Kira E Smith; Nazar Labinskyy; Qun Gao; Gabor Kaley; John G Edwards; Michael S Wolin; Zoltan Ungvari Journal: Am J Pathol Date: 2006-02 Impact factor: 4.307
Authors: Leonard Schwartz; Kevin E Kip; Edwin Alderman; Jiang Lu; Eric R Bates; Vankeepuram Srinivas; Richard G Bach; Lisa D Mighton; Frederick Feit; Spencer King; Robert L Frye Journal: Am J Cardiol Date: 2009-01-12 Impact factor: 2.778
Authors: Koichi Kobayashi; Min Luo; Yue Zhang; David C Wilkes; Gaoxiang Ge; Thomas Grieskamp; Chikaomi Yamada; Ting-Chun Liu; Guorui Huang; Craig T Basson; Andreas Kispert; Daniel S Greenspan; Thomas N Sato Journal: Nat Cell Biol Date: 2008-12-14 Impact factor: 28.824
Authors: Sharon Cresci; Jeremiah P Depta; Petra A Lenzini; Allie Y Li; David E Lanfear; Michael A Province; John A Spertus; Richard G Bach Journal: Circ Cardiovasc Genet Date: 2014-04-24
Authors: Edward D Coverstone; Richard G Bach; LiShiun Chen; Laura J Bierut; Allie Y Li; Petra A Lenzini; Heidi C O'Neill; John A Spertus; Carmen C Sucharov; Jerry A Stitzel; Joel D Schilling; Sharon Cresci Journal: Basic Res Cardiol Date: 2018-08-10 Impact factor: 17.165
Authors: Sharon Cresci; Gerald W Dorn; Philip G Jones; Amber L Beitelshees; Allie Y Li; Petra A Lenzini; Michael A Province; John A Spertus; David E Lanfear Journal: J Am Coll Cardiol Date: 2012-06-13 Impact factor: 24.094
Authors: Li-Shiun Chen; Richard G Bach; Petra A Lenzini; John A Spertus; Laura Jean Bierut; Sharon Cresci Journal: Nicotine Tob Res Date: 2014-04-11 Impact factor: 4.244
Authors: Sheila K Patel; Bryan Wai; Richard J Macisaac; Sharon Grant; Elena Velkoska; Michelle Ord; Sianna Panagiotopoulos; George Jerums; Piyush M Srivastava; Louise M Burrell Journal: Cardiovasc Diabetol Date: 2012-04-26 Impact factor: 9.951
Authors: J P Depta; P A Lenzini; D E Lanfear; T Y Wang; J A Spertus; R G Bach; S Cresci Journal: Pharmacogenomics J Date: 2014-07-08 Impact factor: 3.550